ArticleCancer medicine2025

Delta-He as a Novel Predictive and Prognostic Biomarker in Patients With NSCLC Treated With PD-1/PD-L1 Inhibitors.

Green Hong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.